
#101: Neoclouds, semiconductors and opportunities in healthcare and software
Jul 6, 2026 - 00:22:42
Radio and PodcastLive Radio & Podcasts
Syntara’s highly anticipated Phase 2 results in myelofibrosis—what the data tells us, why the market sold off, and what might come next in terms of funding or partnership.